IO Biotech Inc
NASDAQ:IOBT
IO Biotech Inc
Operating Income
IO Biotech Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IO Biotech Inc
NASDAQ:IOBT
|
Operating Income
-$91.4m
|
CAGR 3-Years
-108%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
Operating Income
kr5.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
31%
|
CAGR 10-Years
54%
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Operating Income
-kr561.2m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-12%
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Operating Income
-€361m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Operating Income
kr2.1B
|
CAGR 3-Years
75%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
51%
|
Bioporto A/S
CSE:BIOPOR
|
Operating Income
-kr60.2m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-12%
|
See Also
What is IO Biotech Inc's Operating Income?
Operating Income
-91.4m
USD
Based on the financial report for Dec 31, 2023, IO Biotech Inc's Operating Income amounts to -91.4m USD.
What is IO Biotech Inc's Operating Income growth rate?
Operating Income CAGR 3Y
-108%
Over the last year, the Operating Income growth was -28%. The average annual Operating Income growth rates for IO Biotech Inc have been -108% over the past three years .